| abstract |
The present invention provides sulfamoyl-arylamides for use in the prevention or treatment of HBV infection in a mammal. A compound of formula (I) or a stereoisomer or tautomeric form thereof, or a pharmaceutically acceptable salt or solvate thereof, a method of producing these compounds, and a pharmaceutical composition comprising them And provides methods for its use alone or in combination with other HBV inhibitors in the treatment of HBV. (B represents a single ring 5- to 6-membered aromatic ring, which optionally comprises one or more heteroatoms each independently selected from the group consisting of O, S and N) 【Selection chart】 None |